Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for perioperative analgesia and postoperative cognitive dysfunction in elderly colorectal surgery patients
ChiCTR2000038378Phase 4Recruiting
- Sponsor
- Guangyuan Central Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain and post-operative cognitive decline (POCD) (3 arms), sponsored by Guangyuan Central Hospital. Primary endpoints: Cognitive function assessment, Pain score and 1 more. Started Sep 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painpost-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2000038378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038378.